Free Trial

Dermata Therapeutics (DRMAW) Stock Trends and Sentiment

$0.0070
0.00 (-14.63%)
(As of 06/10/2024)

Page Views Over Time



Recieve Dermata Therapeutics News and Ratings via Email

Sign-up to receive the latest news and ratings for DRMAW and its competitors with MarketBeat's FREE daily newsletter.

DRMAW Social Media Mentions

Related Companies and Tools

This page (NASDAQ:DRMAW) was last updated on 6/17/2024 by MarketBeat.com Staff

From Our Partners